EP2195022A4 - Compositions comprenant un antigène, un composé amphipathique et un support hydrophobe, et leurs utilisations - Google Patents

Compositions comprenant un antigène, un composé amphipathique et un support hydrophobe, et leurs utilisations

Info

Publication number: EP2195022A4
Authority: EP; European Patent Office
Prior art keywords: antigen; compositions; hydrophobic carrier; amphipathic compound; amphipathic
Prior art date: 2007-10-03
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP08800418A

Other languages

German (de)

English (en)

Other versions

EP2195022A1 (fr

Inventor

Marc Mansour

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Immunovaccine Technologies Inc

Original Assignee

Immunovaccine Technologies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-03

Filing date

2008-10-02

Publication date

2012-08-01

2008-10-02 Application filed by Immunovaccine Technologies Inc filed Critical Immunovaccine Technologies Inc

2010-06-16 Publication of EP2195022A1 publication Critical patent/EP2195022A1/fr

2012-08-01 Publication of EP2195022A4 publication Critical patent/EP2195022A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Oncology (AREA)
Endocrinology (AREA)
Mycology (AREA)
Microbiology (AREA)
Reproductive Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Addiction (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Vascular Medicine (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Biophysics (AREA)
Psychiatry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Zoology (AREA)

EP08800418A 2007-10-03 2008-10-02 Compositions comprenant un antigène, un composé amphipathique et un support hydrophobe, et leurs utilisations Withdrawn EP2195022A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US97719707P	2007-10-03	2007-10-03
PCT/CA2008/001747 WO2009043165A1 (fr)	2007-10-03	2008-10-02	Compositions comprenant un antigène, un composé amphipathique et un support hydrophobe, et leurs utilisations

Publications (2)

Publication Number	Publication Date
EP2195022A1 EP2195022A1 (fr)	2010-06-16
EP2195022A4 true EP2195022A4 (fr)	2012-08-01

Family

ID=40525804

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP08800418A Withdrawn EP2195022A4 (fr)	2007-10-03	2008-10-02	Compositions comprenant un antigène, un composé amphipathique et un support hydrophobe, et leurs utilisations

Country Status (7)

Country	Link
EP (1)	EP2195022A4 (fr)
JP (1)	JP5591705B2 (fr)
CN (1)	CN101815529B (fr)
AU (1)	AU2008307042B2 (fr)
BR (1)	BRPI0817484B1 (fr)
CA (1)	CA2700828C (fr)
WO (1)	WO2009043165A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5731198B2 (ja)	2007-09-27	2015-06-10	イムノバクシーン・テクノロジーズ・インコーポレイテッドＩｍｍｕｎｏｖａｃｃｉｎｅＴｅｃｈｎｏｌｏｇｉｅｓＩｎｃ．	インビボでのポリヌクレオチドの送達のための連続疎水相を含む担体におけるリポソームの使用
CA2723918C (fr)	2008-06-05	2018-01-09	Immunovaccine Technologies Inc.	Compositions contenant des liposomes, un antigene, un polynucleotide et un transporteur comprenant une phase continue d'une substance hydrophobe
CA2850857C (fr) *	2011-10-06	2022-07-26	Immunovaccine Technologies Inc.	Compositions liposomales comprenant un adjuvant qui active ou accroit l'activite de tlr2 et utilisations associees
ES2886999T3 (es)	2013-03-27	2021-12-21	Immunovaccine Technologies Inc	Procedimiento para mejorar la eficacia de una vacuna de survivina en el tratamiento de cáncer
CN107531736B (zh)	2015-01-06	2022-04-15	免疫疫苗科技公司	脂质a模拟物、其制备方法和用途
CN105044328A (zh) *	2015-05-28	2015-11-11	首都医科大学附属北京佑安医院	Elispot预包被培养板及其制备方法
AU2016355926A1 (en) *	2015-11-18	2018-05-31	Immunovaccine Technologies Inc.	Adjuvanting systems and water-free vaccine compositions comprising a polyi:C polynucleotide adjuvant and a lipid-based adjuvant
CA3022924A1 (fr) *	2016-05-04	2017-11-09	Immunovaccine Technologies Inc.	Compositions de vaccin comprenant un compose amphipathique, un neoantigene et un support hydrophobe, et leurs procedes d'utilisation
AU2016425290A1 (en) *	2016-09-27	2019-04-11	Immunovaccine Technologies Inc.	Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjects
US20210147544A1 (en) *	2018-03-20	2021-05-20	Immunovaccine Technologies Inc.	Methods and compositions for targeted delivery of active agents and immunomodulatory agents to lymph nodes
CA3207998A1 (fr) *	2021-02-16	2022-08-25	Geoffrey M. Lynn	Nanoparticules auto-assemblees a base de peptides amphiphiles

Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0640347A1 (fr) *	1992-03-03	1995-03-01	Daiichi Pharmaceutical Co., Ltd.	Vaccin oral
WO1996014871A1 (fr) *	1994-11-15	1996-05-23	Cortecs Limited	Compositions immunogenes
US5736141A (en) *	1992-06-05	1998-04-07	Dalhousie University	Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
WO1998053799A2 (fr) *	1997-05-28	1998-12-03	Jenner Biotherapies, Inc.	Compositions immunogenes
WO2002038175A1 (fr) *	2000-11-07	2002-05-16	Immunovaccine Technologies Inc.	Vaccins a reponse immunitaire accrue et leurs procedes de preparation
WO2007041832A1 (fr) *	2005-10-07	2007-04-19	Immunovaccine Technologies Inc.	Utilisation de liposomes dans un vehicule contenant une phase hydrophobe continue en tant que vehicule de traitement du cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6565885B1 (en) *	1997-09-29	2003-05-20	Inhale Therapeutic Systems, Inc.	Methods of spray drying pharmaceutical compositions
US6956021B1 (en) *	1998-08-25	2005-10-18	Advanced Inhalation Research, Inc.	Stable spray-dried protein formulations

2008
- 2008-10-02 AU AU2008307042A patent/AU2008307042B2/en not_active Ceased
- 2008-10-02 CA CA2700828A patent/CA2700828C/fr active Active
- 2008-10-02 WO PCT/CA2008/001747 patent/WO2009043165A1/fr active Application Filing
- 2008-10-02 JP JP2010527303A patent/JP5591705B2/ja active Active
- 2008-10-02 EP EP08800418A patent/EP2195022A4/fr not_active Withdrawn
- 2008-10-02 CN CN200880110239.7A patent/CN101815529B/zh not_active Expired - Fee Related
- 2008-10-02 BR BRPI0817484-9A patent/BRPI0817484B1/pt not_active IP Right Cessation

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0640347A1 (fr) *	1992-03-03	1995-03-01	Daiichi Pharmaceutical Co., Ltd.	Vaccin oral
US5736141A (en) *	1992-06-05	1998-04-07	Dalhousie University	Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
WO1996014871A1 (fr) *	1994-11-15	1996-05-23	Cortecs Limited	Compositions immunogenes
WO1998053799A2 (fr) *	1997-05-28	1998-12-03	Jenner Biotherapies, Inc.	Compositions immunogenes
WO2002038175A1 (fr) *	2000-11-07	2002-05-16	Immunovaccine Technologies Inc.	Vaccins a reponse immunitaire accrue et leurs procedes de preparation
WO2007041832A1 (fr) *	2005-10-07	2007-04-19	Immunovaccine Technologies Inc.	Utilisation de liposomes dans un vehicule contenant une phase hydrophobe continue en tant que vehicule de traitement du cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HENRY D. STONE: "Newcastle Disease Oil Emulsion Vavvines Prepared with Animal, Vegetable, ans Synthetic Oils", AVIAN DISEASES, vol. 41, 1997, pages 591 - 597, XP008152979 *
See also references of WO2009043165A1 *

Also Published As

Publication number	Publication date
JP2010540570A (ja)	2010-12-24
EP2195022A1 (fr)	2010-06-16
JP5591705B2 (ja)	2014-09-17
CN101815529A (zh)	2010-08-25
CA2700828C (fr)	2017-01-24
CA2700828A1 (fr)	2009-04-09
WO2009043165A1 (fr)	2009-04-09
BRPI0817484B1 (pt)	2021-08-17
BRPI0817484A2 (pt)	2015-03-24
AU2008307042B2 (en)	2014-01-30
AU2008307042A1 (en)	2009-04-09
CN101815529B (zh)	2016-03-09

Publication	Publication Date	Title
EP2195022A4 (fr)	2012-08-01	Compositions comprenant un antigène, un composé amphipathique et un support hydrophobe, et leurs utilisations
HK1214947A1 (zh)	2016-08-12	抗體製劑
PL2035457T3 (pl)	2015-10-30	Nośnik szczepionki
IL193408A0 (en)	2011-08-01	Antibody formulation
EP2077859A4 (fr)	2010-11-24	Formulation d'anticorps
EP2091837A4 (fr)	2010-12-29	Emballage refermable
EP2081453A4 (fr)	2012-07-25	Soutien-gorge à balconnets
EP2040718A4 (fr)	2012-10-03	Formulations de nitrate de gallium
GB2445682B (en)	2009-02-18	Powder handling device
GB0619519D0 (en)	2006-11-15	Packet scheduling
EP2056709A4 (fr)	2013-05-01	Composés luminescents contenant deux sensibilisateurs, conjugués, et leurs utilisations
EP2018782A4 (fr)	2010-04-21	Logique d'ordonnancement
EP2015785A4 (fr)	2009-07-15	Antigène agrm2
EP2080923A4 (fr)	2011-12-28	Embrayage unidirectionnel
GB0601984D0 (en)	2006-03-15	Carrier bag
SG137712A1 (en)	2007-12-28	An improved spreader assembly
EP2018095A4 (fr)	2012-03-14	Support d'instrument
TWI348198B (en)	2011-09-01	Wafer carrier
GB0609165D0 (en)	2006-06-21	Envelope
PT1849714E (pt)	2009-08-10	Embalagem secundária
AU2006904720A0 (en)	2006-09-14	Load Carrier
GB0623913D0 (en)	2007-01-10	Improved carrier
AU2006902726A0 (en)	2006-06-08	Carrier
GB0715248D0 (en)	2007-09-12	Perfumed carrier bags
GB0610013D0 (en)	2006-06-28	Document carrier

Legal Events

Date	Code	Title	Description
2010-05-14	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2010-06-16	17P	Request for examination filed	Effective date: 20100329
2010-06-16	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
2010-06-16	AX	Request for extension of the european patent	Extension state: AL BA MK RS
2011-01-12	DAX	Request for extension of the european patent (deleted)
2012-08-01	A4	Supplementary search report drawn up and despatched	Effective date: 20120628
2012-08-01	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 47/24 20060101ALI20120622BHEP Ipc: A61K 47/48 20060101ALI20120622BHEP Ipc: A61P 31/00 20060101ALI20120622BHEP Ipc: A61K 47/06 20060101ALI20120622BHEP Ipc: A61K 39/39 20060101AFI20120622BHEP
2013-07-31	17Q	First examination report despatched	Effective date: 20130626
2017-09-15	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2017-10-18	18D	Application deemed to be withdrawn	Effective date: 20170516